BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.8 Billion USD | -9.0% |
| 2022 | 6.37 Billion USD | -26.22% |
| 2021 | 8.64 Billion USD | 54.37% |
| 2020 | 5.6 Billion USD | 247.38% |
| 2019 | 1.61 Billion USD | -28.33% |
| 2018 | 2.24 Billion USD | 114.98% |
| 2017 | 1.04 Billion USD | 157.87% |
| 2016 | 405.81 Million USD | 247.55% |
| 2015 | 116.76 Million USD | 117.76% |
| 2014 | 53.62 Million USD | 354.49% |
| 2013 | 11.79 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.71 Billion USD | 0.79% |
| 2024 Q1 | 5.66 Billion USD | -2.37% |
| 2023 Q3 | 5.52 Billion USD | -3.56% |
| 2023 Q4 | 5.8 Billion USD | 5.08% |
| 2023 FY | 5.8 Billion USD | -9.0% |
| 2023 Q1 | 5.95 Billion USD | -6.62% |
| 2023 Q2 | 5.72 Billion USD | -3.83% |
| 2022 Q3 | 6.72 Billion USD | -8.84% |
| 2022 Q2 | 7.37 Billion USD | -8.02% |
| 2022 Q1 | 8.02 Billion USD | -7.22% |
| 2022 FY | 6.37 Billion USD | -26.22% |
| 2022 Q4 | 6.37 Billion USD | -5.15% |
| 2021 Q2 | 5.52 Billion USD | -5.1% |
| 2021 Q4 | 8.64 Billion USD | 63.55% |
| 2021 FY | 8.64 Billion USD | 54.37% |
| 2021 Q1 | 5.82 Billion USD | 3.93% |
| 2021 Q3 | 5.28 Billion USD | -4.3% |
| 2020 Q1 | 4.06 Billion USD | 152.26% |
| 2020 FY | 5.6 Billion USD | 247.38% |
| 2020 Q4 | 5.6 Billion USD | 0.62% |
| 2020 Q3 | 5.56 Billion USD | 42.61% |
| 2020 Q2 | 3.9 Billion USD | -4.03% |
| 2019 Q3 | 1.88 Billion USD | -12.52% |
| 2019 Q4 | 1.61 Billion USD | -14.29% |
| 2019 FY | 1.61 Billion USD | -28.33% |
| 2019 Q1 | 2.17 Billion USD | -3.44% |
| 2019 Q2 | 2.15 Billion USD | -1.01% |
| 2018 Q1 | 1.7 Billion USD | 63.3% |
| 2018 FY | 2.24 Billion USD | 114.98% |
| 2018 Q4 | 2.24 Billion USD | -6.6% |
| 2018 Q3 | 2.4 Billion USD | 45.64% |
| 2018 Q2 | 1.65 Billion USD | -3.22% |
| 2017 Q3 | 1.04 Billion USD | 121.33% |
| 2017 Q1 | 376.72 Million USD | -7.17% |
| 2017 FY | 1.04 Billion USD | 157.87% |
| 2017 Q4 | 1.04 Billion USD | -0.25% |
| 2017 Q2 | 473.97 Million USD | 25.81% |
| 2016 FY | 405.81 Million USD | 247.55% |
| 2016 Q4 | 405.81 Million USD | 72.37% |
| 2016 Q2 | 251.23 Million USD | -5.28% |
| 2016 Q1 | 265.22 Million USD | 127.15% |
| 2016 Q3 | 235.42 Million USD | -6.29% |
| 2015 Q4 | 116.76 Million USD | -13.9% |
| 2015 Q2 | 136.96 Million USD | 0.0% |
| 2015 FY | 116.76 Million USD | 117.76% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q3 | 135.6 Million USD | -0.99% |
| 2014 Q4 | 53.62 Million USD | 0.0% |
| 2014 FY | 53.62 Million USD | 354.49% |
| 2013 FY | 11.79 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -290.115% |
| Alkermes plc | 2.13 Billion USD | -171.754% |
| Agenus Inc. | 313.91 Million USD | -1749.326% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -51.579% |
| Aptorum Group Limited | 20.64 Million USD | -28026.208% |
| Ardelyx, Inc. | 297.57 Million USD | -1850.835% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -658.312% |
| Bicycle Therapeutics plc | 595.34 Million USD | -875.113% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -7776.686% |
| ChromaDex Corporation | 54.96 Million USD | -10461.959% |
| Chimerix, Inc. | 212.77 Million USD | -2628.376% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -20433.37% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -1216.484% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -160.376% |
| Precision BioSciences, Inc. | 159.78 Million USD | -3533.27% |
| Dyadic International, Inc. | 8.21 Million USD | -70530.348% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -18190.091% |
| Fortress Biotech, Inc. | 167.52 Million USD | -3365.298% |
| Lantern Pharma Inc. | 43.64 Million USD | -13200.325% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -3498.229% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -39918.034% |
| Incyte Corporation | 6.78 Billion USD | 14.403% |
| IO Biotech, Inc. | 150.71 Million USD | -3751.746% |
| Jaguar Health, Inc. | 50.76 Million USD | -11336.036% |
| Novavax, Inc. | 1.85 Billion USD | -212.895% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -1426.069% |
| Opthea Limited | 188.79 Million USD | -2974.971% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -596.858% |
| ContextLogic Inc. | 423 Million USD | -1272.405% |
| MiMedx Group, Inc. | 239.04 Million USD | -2328.508% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -3241.627% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -112194.212% |
| NextCure, Inc. | 129.41 Million USD | -4385.678% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -10660.872% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -15705.698% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -17872.431% |
| Vaxcyte, Inc. | 1.4 Billion USD | -312.331% |
| PDS Biotechnology Corporation | 59.39 Million USD | -9674.823% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -806.3% |
| Pharming Group N.V. | 462.85 Million USD | -1154.235% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -14908.467% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -823.591% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -30577.313% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -30577.313% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -3411.538% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -12718.855% |
| Acelyrin, Inc. | 742.69 Million USD | -681.655% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -88038.689% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -90564.923% |
| Summit Therapeutics Inc. | 202.94 Million USD | -2760.46% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -7705.517% |
| Senti Biosciences, Inc. | 119.48 Million USD | -4758.621% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -2442.36% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -3351.946% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -70156.263% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -121507.816% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -1137.292% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -4594.811% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -2011.401% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -1127.746% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -57349.53% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -2606.346% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -512661.458% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -1302.776% |
| Immix Biopharma, Inc. | 19.92 Million USD | -29035.4% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -1468.887% |
| MEI Pharma, Inc. | 41.37 Million USD | -13930.876% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -17814.198% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -1603.436% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -4852.25% |
| Fortress Biotech, Inc. | 167.52 Million USD | -3365.298% |
| Precigen, Inc. | 151.04 Million USD | -3743.458% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -16965.304% |
| AlloVir, Inc. | 190.79 Million USD | -2942.661% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -1442.106% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -1046.796% |
| ImmuCell Corporation | 43.8 Million USD | -13151.601% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -794.06% |
| Onconetix, Inc. | 88.82 Million USD | -6435.893% |
| PureTech Health plc | 693.97 Million USD | -736.528% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -5842.852% |
| Elevation Oncology, Inc. | 89.09 Million USD | -6416.118% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -93503.273% |
| Seer, Inc. | 436.26 Million USD | -1230.664% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -7014.569% |
| Innoviva, Inc. | 1.24 Billion USD | -366.847% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -4283.887% |
| ESSA Pharma Inc. | 149.12 Million USD | -3792.967% |
| GlycoMimetics, Inc. | 45.31 Million USD | -12710.518% |
| GT Biopharma, Inc. | 14.1 Million USD | -41045.9% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -1785.485% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -2301.822% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -1130.174% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -11350.924% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -5997.209% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -919055.367% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -925.049% |
| Aptose Biosciences Inc. | 12.92 Million USD | -44823.623% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -26151.246% |
| Soligenix, Inc. | 9.79 Million USD | -59153.668% |
| Century Therapeutics, Inc. | 360.69 Million USD | -1509.487% |
| Kura Oncology, Inc. | 448.93 Million USD | -1193.121% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -2033.124% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -33466.204% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -5134.159% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -2729.757% |
| Autolus Therapeutics plc | 375.38 Million USD | -1446.502% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -2207.013% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -1534.442% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -11715.67% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -778.078% |
| GRI Bio, Inc. | 2.95 Million USD | -196289.547% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -54639.758% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -3304.554% |
| IGM Biosciences, Inc. | 423.41 Million USD | -1271.073% |
| INmune Bio, Inc. | 57 Million USD | -10084.514% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -2509.042% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -6815.878% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -22128.076% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -84239.831% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -7617.112% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -3842.248% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -3407.634% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -822.052% |
| Verastem, Inc. | 149.71 Million USD | -3777.473% |
| Abeona Therapeutics Inc. | 64 Million USD | -8970.459% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -1033.502% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -3658.506% |
| Histogen Inc. | 19.07 Million USD | -30337.136% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -25530.156% |
| Surrozen, Inc. | 46.08 Million USD | -12498.253% |
| Organovo Holdings, Inc. | 6.34 Million USD | -91336.053% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -134636.296% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -3930.691% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -49088.909% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -7612.806% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -68043.029% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -1499.386% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -31983.274% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -1251.944% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -45930.795% |
| Apollomics, Inc. | 55.38 Million USD | -10381.295% |
| Amarin Corporation plc | 831.68 Million USD | -598.015% |
| Mesoblast Limited | 669.15 Million USD | -767.556% |
| Turnstone Biologics Corp. | 112.81 Million USD | -5045.836% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -908.282% |
| Synaptogenix, Inc. | 31.11 Million USD | -18558.28% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -47546.709% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -959.237% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -98759.281% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -78935.389% |
| Exelixis, Inc. | 2.94 Billion USD | -97.3% |
| Better Therapeutics, Inc. | 22.94 Million USD | -25203.034% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -1492.498% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -636.028% |
| NLS Pharmaceutics AG | 1.84 Million USD | -314269.442% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -72660.262% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -39405.104% |
| Gritstone bio, Inc. | 177.76 Million USD | -3165.628% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -5986.47% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -32400.209% |
| Avid Bioservices, Inc. | 336.55 Million USD | -1624.901% |
| Insmed Incorporated | 1.32 Billion USD | -336.54% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -60193.591% |
| MediWound Ltd. | 66.45 Million USD | -8635.122% |
| OmniAb, Inc. | 401.98 Million USD | -1344.152% |
| Alector, Inc. | 621.82 Million USD | -833.584% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -1518.872% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -107844.868% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -10140.025% |
| Zai Lab Limited | 1.03 Billion USD | -460.195% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -1113.34% |
| Aura Biosciences, Inc. | 255.07 Million USD | -2175.909% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -674.007% |
| Immunic, Inc. | 54.29 Million USD | -10591.311% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -2080.598% |
| Veracyte, Inc. | 1.13 Billion USD | -410.21% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -49002.445% |
| FibroGen, Inc. | 423.52 Million USD | -1270.691% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -165151.21% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -122461.94% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -106821.42% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 49.047% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -65831.573% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -1021.892% |
| TG Therapeutics, Inc. | 329.58 Million USD | -1661.379% |
| Galecto, Inc. | 38.22 Million USD | -15086.321% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -20144.368% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -33.234% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -2366.09% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -23268.791% |
| XBiotech Inc. | 227.24 Million USD | -2454.655% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -5986.47% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -3971.02% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -1930.413% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -4440.018% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -1419.709% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -289.351% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -1491.175% |
| Vaxxinity, Inc. | 44.35 Million USD | -12988.799% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -1022.964% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -31095.506% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -1803.057% |
| NexImmune, Inc. | 8.59 Million USD | -67450.727% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -54077.994% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -33794.684% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 82.451% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -26107.578% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -1479837.032% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -3249.281% |
| Ainos, Inc. | 31.84 Million USD | -18131.615% |
| Pluri Inc. | 39.52 Million USD | -14586.86% |
| Prothena Corporation plc | 696.38 Million USD | -733.634% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -1954.121% |
| Celularity Inc. | 143.88 Million USD | -3934.551% |
| Rallybio Corporation | 115.62 Million USD | -4920.996% |
| Cue Biopharma, Inc. | 61.53 Million USD | -9334.869% |
| MeiraGTx Holdings plc | 458.16 Million USD | -1167.063% |
| Omeros Corporation | 378.26 Million USD | -1434.695% |
| Humacyte, Inc. | 128.22 Million USD | -4427.483% |
| Immunocore Holdings plc | 597 Million USD | -872.406% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -18471.531% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -8371.144% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -453.279% |
| CalciMedica, Inc. | 12.18 Million USD | -47542.799% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -2188.695% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -3296.725% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -1766.438% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -926.939% |
| Pulmatrix, Inc. | 33.95 Million USD | -16995.456% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -21285.379% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -4021.367% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -346.224% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -4359.112% |
| Cytokinetics, Incorporated | 824.31 Million USD | -604.254% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -27383.194% |
| Nutriband Inc. | 7.51 Million USD | -77127.033% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -7252.731% |
| Vor Biopharma Inc. | 209.82 Million USD | -2666.683% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 19.622% |
| Evogene Ltd. | 51.1 Million USD | -11260.394% |
| ProKidney Corp. | 420.55 Million USD | -1280.394% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -10487.192% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -60877.999% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -962.498% |
| CorMedix Inc. | 82.05 Million USD | -6974.431% |
| BioLineRx Ltd. | 63.92 Million USD | -8981.384% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -1342.064% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -20486.082% |
| Atai Life Sciences N.V. | 293.47 Million USD | -1878.095% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -3458.692% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -4456.087% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -932.917% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -5902.207% |
| MediciNova, Inc. | 66.26 Million USD | -8660.038% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -6500.804% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -129994.132% |
| GeoVax Labs, Inc. | 9.28 Million USD | -62435.151% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -886.896% |
| Biomea Fusion, Inc. | 199.92 Million USD | -2803.697% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -205.03% |
| Mereo BioPharma Group plc | 66.49 Million USD | -8629.868% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -1096.727% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -847.212% |
| Absci Corporation | 234.48 Million USD | -2375.808% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -79261.244% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -1607.981% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -3416.601% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -1002.989% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -1990.537% |
| Allakos Inc. | 243.61 Million USD | -2283.02% |
| Imunon, Inc. | 21.91 Million USD | -26386.252% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -2152.778% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -834.049% |
| BioAtla, Inc. | 119.65 Million USD | -4751.556% |
| NLS Pharmaceutics AG | 1.84 Million USD | -314269.442% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -180188.043% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -803.071% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -5951.259% |
| XOMA Corporation | 234.3 Million USD | -2377.7% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -2524.031% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -4513.073% |
| aTyr Pharma, Inc. | 122.06 Million USD | -4655.81% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -3672.035% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -900.442% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -1083.726% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -5155.117% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -38199.538% |
| Akari Therapeutics, Plc | 4.35 Million USD | -133201.378% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -33973.848% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -234.932% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -188139.343% |
| UroGen Pharma Ltd. | 178.31 Million USD | -3155.702% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -1133.234% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -1044549.686% |
| Orgenesis Inc. | 14.55 Million USD | -39793.314% |
| Entera Bio Ltd. | 11.76 Million USD | -49243.604% |
| GH Research PLC | 226.3 Million USD | -2465.3% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -10514.098% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -5303.473% |
| Xencor, Inc. | 952.69 Million USD | -509.355% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -74481.78% |
| Replimune Group, Inc. | 487.72 Million USD | -1090.284% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -71826.787% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -795.268% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -188139.343% |
| Portage Biotech Inc. | 7.77 Million USD | -74527.523% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -129994.132% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -1996.183% |
| OncoCyte Corporation | 74.89 Million USD | -7651.529% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -285417.31% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -100221.983% |
| Purple Biotech Ltd. | 44.3 Million USD | -13003.867% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -16911.296% |
| scPharmaceuticals Inc. | 94.47 Million USD | -6044.514% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -32071.175% |
| HilleVax, Inc. | 344.43 Million USD | -1585.454% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -182685.737% |
| Tharimmune, Inc. | 10.94 Million USD | -52933.68% |
| Genprex, Inc. | 10.67 Million USD | -54304.432% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -1069.958% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -5931.329% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -239194.106% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -139267.596% |
| OKYO Pharma Limited | 1.54 Million USD | -376556.757% |
| Savara Inc. | 177.56 Million USD | -3169.399% |
| Curis, Inc. | 77.28 Million USD | -7411.807% |
| Daré Bioscience, Inc. | 21.28 Million USD | -27177.588% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -8978.004% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -71694.15% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -29868.897% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -47605.44% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -177.952% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -1521.807% |
| Erasca, Inc. | 395.29 Million USD | -1368.586% |
| bluebird bio, Inc. | 619.16 Million USD | -837.603% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -134176.649% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 15.147% |
| DBV Technologies S.A. | 182.98 Million USD | -3072.524% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -134176.649% |
| Moderna, Inc. | 18.42 Billion USD | 68.494% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -31767.349% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -50005.947% |
| Molecular Templates, Inc. | 35.38 Million USD | -16306.961% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -4098.658% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -635.857% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -1811.17% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -5484.895% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -1146.765% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -1752.135% |
| MacroGenics, Inc. | 306.82 Million USD | -1792.078% |
| RenovoRx, Inc. | 1.46 Million USD | -395894.202% |
| Adicet Bio, Inc. | 207.29 Million USD | -2700.49% |
| Prime Medicine, Inc. | 193.85 Million USD | -2894.71% |
| Aditxt, Inc. | 44.57 Million USD | -12922.64% |
| Adagene Inc. | 115.72 Million USD | -4916.273% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -130232.929% |
| Quantum-Si incorporated | 298.25 Million USD | -1846.446% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -290.284% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -75203.961% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -1552.601% |
| SciSparc Ltd. | 11.18 Million USD | -51816.249% |
| Vericel Corporation | 353.65 Million USD | -1541.499% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -47435.093% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -10102.483% |
| Generation Bio Co. | 374.75 Million USD | -1449.073% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -2179.564% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -3561.086% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -1600.606% |
| Invivyd, Inc. | 229.18 Million USD | -2433.052% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -587.845% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -47604.26% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -3082.891% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -28323.791% |
| 2seventy bio, Inc. | 565.42 Million USD | -926.708% |
| ADMA Biologics, Inc. | 329.18 Million USD | -1663.546% |
| Clene Inc. | 52.34 Million USD | -10991.257% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -9783.956% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -4369.24% |
| GeoVax Labs, Inc. | 9.28 Million USD | -62435.151% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -788.065% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -5502.944% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -4352.376% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -5850.952% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -8076.789% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -2293.405% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -196.174% |
| Evaxion Biotech A/S | 12.88 Million USD | -44941.87% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -2203.132% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -671.272% |
| Trevena, Inc. | 40.6 Million USD | -14196.946% |
| Surrozen, Inc. | 46.08 Million USD | -12498.253% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -2470.332% |
| Cingulate Inc. | 3.49 Million USD | -166171.843% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -34810.548% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -8737.38% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -49583.015% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -2061.977% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -675.116% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -4511.314% |
| Clearmind Medicine Inc. | 4.32 Million USD | -134144.977% |
| Kronos Bio, Inc. | 213.27 Million USD | -2621.916% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -3533.202% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -67713.801% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -1475.423% |
| Statera Biopharma, Inc. | 21.16 Million USD | -27322.586% |
| ImmunityBio, Inc. | 504.45 Million USD | -1050.808% |
| Korro Bio, Inc. | 221.66 Million USD | -2518.964% |
| Kineta, Inc. | 10.28 Million USD | -56366.054% |
| BioVie Inc. | 25.2 Million USD | -22929.179% |
| Codexis, Inc. | 136.56 Million USD | -4151.049% |
| Celularity Inc. | 143.88 Million USD | -3934.551% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -813.709% |
| Celcuity Inc. | 191.21 Million USD | -2935.924% |
| Virax Biolabs Group Limited | 5.48 Million USD | -105759.005% |
| Cibus, Inc. | 544.41 Million USD | -966.341% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -4511.24% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -28157.764% |
| IN8bio, Inc. | 33.7 Million USD | -17121.736% |
| Kodiak Sciences Inc. | 479.37 Million USD | -1111.017% |
| Annexon, Inc. | 297.67 Million USD | -1850.212% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -3255.456% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -4122.97% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -27553.384% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -94.152% |
| Eyenovia, Inc. | 28.77 Million USD | -20071.651% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -2418.252% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -80260.95% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -9428.403% |
| Arcellx, Inc. | 825.13 Million USD | -603.557% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -7011.083% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -1155.806% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -18778.943% |
| Moolec Science SA | 24.05 Million USD | -24037.064% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -1771.915% |
| Geron Corporation | 394.07 Million USD | -1373.136% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -5607.674% |
| Royalty Pharma plc | 16.38 Billion USD | 64.563% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -875.729% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -82893.975% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -48167.419% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -2468.024% |
| Humacyte, Inc. | 128.22 Million USD | -4427.483% |
| Structure Therapeutics Inc. | 482.01 Million USD | -1104.371% |
| 89bio, Inc. | 596.26 Million USD | -873.6% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -2202.292% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -313698.649% |
| Genelux Corporation | 27.89 Million USD | -20712.659% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -6393.378% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -2430.314% |
| Notable Labs, Ltd. | 19.54 Million USD | -29608.178% |
| Liquidia Corporation | 120.43 Million USD | -4720.416% |
| Mustang Bio, Inc. | 17.74 Million USD | -32620.522% |
| Immunovant, Inc. | 666.71 Million USD | -770.732% |
| Quantum-Si incorporated | 298.25 Million USD | -1846.446% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -3920.246% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -10618.75% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -3206.982% |
| Acasti Pharma Inc. | 73.3 Million USD | -7819.884% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -127424.531% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -22128.076% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -501.709% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -111756.777% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -25382.968% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -11149.879% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -3112.819% |
| PepGen Inc. | 143.05 Million USD | -3958.157% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -15090.295% |
| United Therapeutics Corporation | 7.16 Billion USD | 19.0% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -30159.447% |
| Solid Biosciences Inc. | 164.93 Million USD | -3419.65% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -98759.281% |
| Immuneering Corporation | 102.58 Million USD | -5559.016% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -134636.296% |
| Silo Pharma, Inc. | 7.74 Million USD | -74844.092% |
| Belite Bio, Inc | 94.64 Million USD | -6033.931% |
| XOMA Corporation | 234.3 Million USD | -2377.7% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -2389.526% |
| Bionomics Limited | 27.64 Million USD | -20896.258% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -1346.242% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -5305.888% |
| uniQure N.V. | 831.68 Million USD | -598.01% |
| Cassava Sciences, Inc. | 151.66 Million USD | -3727.746% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -130232.929% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -2019.603% |
| Forte Biosciences, Inc. | 38.98 Million USD | -14792.958% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -142426.701% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -15661.926% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -80260.95% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -165151.21% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -49009.847% |
| Altimmune, Inc. | 210.64 Million USD | -2656.017% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -646.294% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -5305.888% |
| Compugen Ltd. | 121.33 Million USD | -4684.541% |
| Peak Bio, Inc. | 2.59 Million USD | -223488.101% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -3268.755% |
| Benitec Biopharma Inc. | 52.21 Million USD | -11019.086% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -1598.149% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -16594.778% |
| Zura Bio Limited | 100.84 Million USD | -5656.746% |
| PolyPid Ltd. | 15.37 Million USD | -37665.255% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -4766.686% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -16594.778% |
| Instil Bio, Inc. | 325.63 Million USD | -1682.783% |
| argenx SE | 4.54 Billion USD | -27.8% |
| Immunome, Inc. | 148.54 Million USD | -3808.223% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -3600.574% |
| Verona Pharma plc | 308.12 Million USD | -1784.071% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -6575.876% |
| Shattuck Labs, Inc. | 159.56 Million USD | -3538.211% |
| CervoMed Inc. | 9.97 Million USD | -58112.713% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -2980.441% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -50877.125% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -3135.849% |
| Moolec Science SA | 24.05 Million USD | -24037.064% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -94796.51% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -3256.729% |
| AnaptysBio, Inc. | 452.38 Million USD | -1183.248% |
| Design Therapeutics, Inc. | 289.64 Million USD | -1904.286% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -7871.541% |
| NeurAxis, Inc. | 509.49 Thousand USD | -1139310.753% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -107047.933% |
| Lumos Pharma, Inc. | 40.63 Million USD | -14185.336% |
| Achilles Therapeutics plc | 161.45 Million USD | -3495.577% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -6575.876% |
| 180 Life Sciences Corp. | 5.25 Million USD | -110277.441% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -8142.874% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -67713.801% |
| Nutriband Inc. | 7.51 Million USD | -77127.033% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -2179.385% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -2812.818% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -7517.272% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -9923.612% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -1002.532% |
| Palisade Bio, Inc. | 14.05 Million USD | -41212.802% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -2660.539% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -297.699% |
| Neurogene Inc. | 222.57 Million USD | -2508.257% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -797.786% |
| AEON Biopharma, Inc. | 6.84 Million USD | -84710.446% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -1181.416% |
| Sesen Bio, Inc. | 189.17 Million USD | -2968.749% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -2035.336% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -42237.588% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -643.931% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -2074.309% |
| Athira Pharma, Inc. | 160.24 Million USD | -3522.75% |
| Vaccinex, Inc. | 3.63 Million USD | -159780.887% |
| HCW Biologics Inc. | 28.51 Million USD | -20259.628% |
| XOMA Corporation | 234.3 Million USD | -2377.7% |
| Nektar Therapeutics | 398.03 Million USD | -1358.491% |
| Arvinas, Inc. | 1.3 Billion USD | -344.985% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -33973.848% |
| Merus N.V. | 458.49 Million USD | -1166.162% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -2740.627% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -3121.502% |
| Rezolute, Inc. | 132.73 Million USD | -4273.517% |
| Clene Inc. | 52.34 Million USD | -10991.257% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -38799.239% |
| BeyondSpring Inc. | 24.8 Million USD | -23300.818% |
| Synlogic, Inc. | 75.55 Million USD | -7584.017% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -48840.103% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -61895.675% |
| Peak Bio, Inc. | 2.59 Million USD | -223488.101% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -3220.469% |
| Krystal Biotech, Inc. | 818.35 Million USD | -609.383% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -2314.458% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -699.858% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -162186.626% |
| MannKind Corporation | 475.19 Million USD | -1121.654% |
| Ikena Oncology, Inc. | 192.09 Million USD | -2922.133% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -43307.171% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -4881.401% |
| Gossamer Bio, Inc. | 311.91 Million USD | -1761.166% |
| CohBar, Inc. | 16.36 Million USD | -35372.279% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -16409.612% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -79261.244% |
| Legend Biotech Corporation | 1.84 Billion USD | -214.035% |
| Mural Oncology plc | 301.74 Million USD | -1823.901% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -18497.709% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -102098.259% |
| Disc Medicine, Inc. | 367.99 Million USD | -1477.538% |
| Champions Oncology, Inc. | 26.13 Million USD | -22115.196% |
| REGENXBIO Inc. | 573.97 Million USD | -911.425% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -214268.271% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -3660.234% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -47974.502% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -1607.258% |
| Vaxart, Inc. | 91.83 Million USD | -6221.763% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -9590.983% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -3813.838% |
| Cellectis S.A. | 334.27 Million USD | -1636.702% |
| Longeveron Inc. | 12.17 Million USD | -47570.184% |
| Repare Therapeutics Inc. | 253.9 Million USD | -2186.433% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -77.826% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -2790.397% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -177.952% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -357147.692% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -1990.402% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -3459.378% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -4084.163% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -22646.16% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 74.46% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -403.093% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -47435.093% |
| Veru Inc. | 50.59 Million USD | -11373.8% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -12644.001% |
| Cingulate Inc. | 3.49 Million USD | -166171.843% |
| Passage Bio, Inc. | 150.54 Million USD | -3756.173% |
| Context Therapeutics Inc. | 16.06 Million USD | -36041.261% |
| Exicure, Inc. | 11.58 Million USD | -50031.908% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -1443.759% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -3491.44% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -33126.162% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -1644.662% |
| Nuvalent, Inc. | 732.38 Million USD | -692.655% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -38746.656% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -6382.43% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -40808.146% |
| OmniAb, Inc. | 401.98 Million USD | -1344.152% |
| Anew Medical, Inc. | 19.45 Million USD | -29738.04% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -21621.0% |
| Lipocine Inc. | 23 Million USD | -25139.15% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -4052.349% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -1799.849% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -6815.878% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -4676.432% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -73060.365% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -557.988% |
| Ocugen, Inc. | 64.54 Million USD | -8893.873% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -4561.336% |
| Q32 Bio Inc. | 306.11 Million USD | -1796.411% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -137858.056% |
| Alumis Inc. Common Stock | 89.61 Million USD | -6378.234% |
| Equillium, Inc. | 50.53 Million USD | -11388.769% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -7620.294% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -13965.373% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -341215.505% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -22107.548% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -8908.667% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -155657.955% |
| Dominari Holdings Inc. | 57.55 Million USD | -9985.957% |
| Edesa Biotech, Inc. | 8.89 Million USD | -65197.971% |
| vTv Therapeutics Inc. | 11.01 Million USD | -52589.009% |
| Bio-Techne Corporation | 2.81 Billion USD | -106.359% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -519.482% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -615.422% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -1990.748% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -13820.855% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -769.589% |
| Nkarta, Inc. | 378.88 Million USD | -1432.2% |
| BioCardia, Inc. | 2.98 Million USD | -194251.356% |
| Iterum Therapeutics plc | 26.25 Million USD | -22007.754% |